![Thomas Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 54 975 $ in data 31/08/2026
Thomas W.
Lynch is currently Director at Bioforward, Inc. and Chief Business Officer at MindWalk Holdings Corp.
Starting in 2025, the role at MindWalk Holdings Corp.
began.
Formerly, Dr. Lynch was Vice President-Global Sales & Client Services at Aldevron LLC.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/07/2026 | 41.026 ( 0,09% ) | 54 975 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Corporate Officer/Principal | 20/10/2025 |
Bioforward, Inc.
 Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
Bioforward, Inc.
Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Finance |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
